Martin & CO Inc Amgen Inc Transaction History

Martin & CO Inc

$394 Million
Q3 2024

A detailed history of Martin & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Martin & CO Inc holds 4,949 shares of AMGN stock, worth $1.46 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

4,949

Previous 4,953 0.08%

Holding current value

$1.46 Million

Previous $1.55 Million 3.04%

% of portfolio

0.4%

Previous 0.42%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $1,237 - $1,349	-4 Reduced 0.08%	4,949 $1.59 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $2,627 - $3,193	-10 Reduced 0.2%	4,953 $1.55 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $42,212 - $50,955	-157 Reduced 3.07%	4,963 $1.41 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $57,532 - $64,903	-225 Reduced 4.21%	5,120 $1.47 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $5,466 - $6,786	-25 Reduced 0.47%	5,345 $1.44 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $54,424 - $64,355	-254 Reduced 4.52%	5,370 $1.19 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $62,318 - $75,955	-276 Reduced 4.68%	5,624 $1.36 Million
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $139,250 - $176,934	608 Added 11.49%	5,900 $1.55 Million
Q3 2022 Oct 26, 2022	BUY	$224.46 - $253.15 $16,610 - $18,733	74 Added 1.42%	5,292 $1.19 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $2,307 - $2,567	-10 Reduced 0.19%	5,218 $1.27 Million
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $81,568 - $90,236	-372 Reduced 6.64%	5,228 $1.26 Million
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $12,131 - $13,883	-61 Reduced 1.08%	5,600 $1.26 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $104,012 - $121,863	490 Added 9.48%	5,661 $1.2 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $55,124 - $61,157	-236 Reduced 4.36%	5,171 $1.26 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $36,393 - $42,410	-164 Reduced 2.94%	5,407 $1.35 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $5,409 - $6,441	25 Added 0.45%	5,571 $1.28 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $21,118 - $23,485	-90 Reduced 1.6%	5,546 $1.41 Million
Q2 2020 Aug 19, 2020	SELL	$197.81 - $242.74 $2,967 - $3,641	-15 Reduced 0.27%	5,636 $1.33 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $14,943 - $19,819	82 Added 1.47%	5,651 $1.15 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $4,730 - $6,080	-25 Reduced 0.45%	5,569 $1.34 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $4,352 - $5,215	-25 Reduced 0.44%	5,594 $1.08 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $20,837 - $24,426	-125 Reduced 2.18%	5,619 $1.04 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $83,200 - $93,784	-460 Reduced 7.41%	5,744 $1.09 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $9,812 - $11,453	-55 Reduced 0.88%	6,204 $1.21 Million
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $22,234 - $25,066	-120 Reduced 1.88%	6,259 $1.3 Million
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $943,662 - $1.06 Million	-5,683 Reduced 47.11%	6,379 $1.18 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $18,637 - $21,780	-110 Reduced 0.9%	12,062 $2.06 Million
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $14,347 - $16,030	-85 Reduced 0.69%	12,172 $2.12 Million
Q3 2017 Nov 15, 2017	SELL	$167.29 - $191.0 $204,093 - $233,020	-1,220 Reduced 9.05%	12,257 $2.29 Million
Q2 2017 Aug 15, 2017	BUY	N/A	13,477	13,477 $2.32 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Martin & CO Inc with notifications on news.

Account